Semaglutide

Semaglutide – Research Compound Overview

Semaglutide is a synthetic GLP-1 receptor agonist peptide widely studied for its metabolic and glycemic effects. It mimics the natural incretin hormone GLP-1, supporting improved insulin regulation, appetite control, and energy metabolism.

Research indicates Semaglutide may influence body composition, glucose balance, and cardiovascular health through enhanced insulin sensitivity, delayed gastric emptying, and reduced caloric intake. Ongoing studies continue to explore its role in metabolic and longevity-related pathways.

Molecular Type: GLP-1 analog
Form: Lyophilized peptide, 10–30 mg vials